Increased tumor necrosis factor α-converting enzyme activity induces insulin resistance and hepatosteatosis in mice

Hepatology

Volumn 51, Issue 1, 2010, Pages 103-110

  Fiorentino, Loredana ^a   Vivanti, Alessia ^a   Cavalera, Michele ^a   Marzano, Valeria ^a,b   Ronci, Maurizio ^a,b   Fabrizi, Marta ^a   Menini, Stefano ^c   Pugliese, Giuseppe ^c   Menghini, Rossella ^a   Khokha, Rama ^d   Lauro, Renato ^a   Urbani, Andrea ^a,b   Federici, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S Lucia Research Institute   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE KINASE; FATTY ACID; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 1; GLUCOSE; GLYCINE METHYLTRANSFERASE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; LIPOPOLYSACCHARIDE; METHIONINE; METHIONINE ADENOSYLTRANSFERASE; PALMITIC ACID; PROTEIN KINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ADENOVIRUS; ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY LIVER; GENE OVEREXPRESSION; IN VIVO STUDY; INSULIN RESISTANCE; LIPID DIET; LIVER CELL; MOUSE; MUSCLE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEOMICS; WHITE ADIPOSE TISSUE; WILD TYPE;

ADAM PROTEINS; ANIMALS; DIETARY FATS; FATTY LIVER; INSULIN RESISTANCE; MICE; PROTEOMICS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 73449086315     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23250     Document Type: Article

References (30)

1. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. HEPATOLOGY 2009;49:306-317.
2. Postic C, Girard J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 2008;34:643-648.
3. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829-838.
4. Adachi M, Osawa Y, Uchinami H, Kitamura T, Accili D, Brenner DA. The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology 2007;132:1434-1446.
5. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. HEPATOLOGY 2004;40:185-194.
6. Murphy G, Murthy A, Khokha R. Clipping, shedding and RIPping keep immunity on cue. Trends Immunol 2008;29:75-82.
7. Reddy AB, Ramana KV, Srivastava S, Bhatnagar A, Srivastava SK. Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells. Endocrinology 2009;150:63-74.
8. Soond SM, Everson B, Riches DW, Murphy G. ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. J Cell Sci 2005;118:2371-2380.
9. Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and TACE. Proc Natl Acad Sci U S A 2007;104:19796-19801.
10. Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, et al. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest 2005;115:3494-3505.
11. Serino M, Menghini R, Fiorentino L, Amoruso R, Mauriello A, Lauro D, et al. Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes 2007;56:2541-2546.
12. Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V, et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 2009;136:663-672.
13. Menghini R, Marchetti V, Cardellini M, Hribal ML, Mauriello A, Lauro D, et al. Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. Circulation 2005;111:1946-1953.
14. Hribal ML, Nakae J, Kitamura T, Shutter JR, Accili D. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol 2003;162:535-541.
15. Kim JJ, Park BC, Kido Y, Accili D. Mitogenic and metabolic effects of type I IGF receptor overexpression in insulin receptor-deficient hepatocytes. Endocrinology 2001;142:3354-3360.
16. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, et al. Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 2004;36:969-977.
17. Vissers JP, Langridge JI, Aerts JM. Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics 2007;6:755-766.
18. Ronci M, Bonanno E, Colantoni A, Pieroni L, Di Ilio C, Spagnoli LG, et al. Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations. Proteomics 2008;8:3702-3714.
19. Wang W, Kramer PM, Yang S, Pereira MA, Tao L. Reversed-phase highperformance liquid chromatography procedure for the simultaneous determination of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the effect of methionine on their concentrations. J Chromatogr B Biomed Sci Appl 2001;762:59-65.
20. Kotb M, Mudd SH, Mato JM, Geller AM, Kredich NM, Chou JY, et al. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet 1997;13:51-52.
21. Mato JM, Mart?́nez-Chantar ML, Lu SC. Methionine metabolism and liver disease. Annu Rev Nutr 2008;28:273-293.
22. Calvert VS, Collantes R, Elariny H, Afendy A, Baranova A, Mendoza M, et al. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. HEPATOLOGY 2007;46:166-172.
23. Diamond DL, Proll SC, Jacobs JM, Chan EY, Camp DG 2nd, Smith RD, et al. HepatoProteomics: applying proteomic technologies to the study of liver function and disease. HEPATOLOGY 2006;44:299-308.
24. Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. HEPATOLOGY 2005;42:665-674.
25. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 2007;6:208-216.
26. Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 2006;116:2464-2472.
27. Boison D, Scheurer L, Zumsteg V, Rülicke T, Litynski P, Fowler B, et al. Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci U S A 2002;99:6985-6990.
28. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A 2001;98:5560-5565.
29. Martínez-Chantar ML, Vázquez-Chantada M, Ariz U, Martínez N, Varela M, Luka Z, et al. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. HEPATOLOGY 2008;47:1191-1199.
30. Newberry EP, Xie Y, Kennedy SM, Luo J, Davidson NO. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. HEPATOLOGY 2006;44:1191-1205.